Mon, 05 Jan 2009 12:15:59 GMT
-- Antioxidant supplementation was found to be effective in relieving pain and reducing levels of oxidative stress in patients with chronic pancreatitis (CP), reports a new study in Gastroenterology. CP is a progressive inflammatory disease of the pancreas in which patients experience abdominal pain (in early stage) and diabetes and maldigestion (in late stage).
Tue, 06 Jan 2009 02:36:54 GMT
-- The central government has sanctioned Rs 100 crore to the Karnataka government as part of the Pradhana Mantri Swasthya Surkasha Yojana (PMSSY). The funds will be utilized to upgrade the Bangalore Medical College to the rank of the All India Institute of Medical Sciences (AIIMS). The total upgradation of the project involves Rs 120 crore and the state government is expected to chip in Rs 20 crore.
Mon, 05 Jan 2009 16:14:59 GMT
-- A study published today in the Journal of Clinical Oncology demonstrates that the addition of Erbitux® (cetuximab) to standard oxaliplatin-based chemotherapy (FOLFOX-4) in previously untreated metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors results in significantly higher efficacy than chemotherapy alone.
Tue, 06 Jan 2009 06:00:00 GMT
-- --Depomed, Inc. announced today that the previously announced product license agreement under which Solvay Pharmaceuticals will have exclusive rights for DM-1796 for the treatment of pain in the United States, Canada, Mexico and Puerto Rico, has cleared review under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
